Original Research
Published on 21 Jan 2020
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01568
- 10,948 views
- 43 citations
